DPP4 and Sepsis: In the following two subsections, we will present and discuss our recent findings on anti-inflammatory effects of SGLT-2 inhibitors, GLP-1 agonists, and DPP-4 inhibitors in animal models of diabetes type 1/2 as well as experimental sepsis.